266 related articles for article (PubMed ID: 18084892)
1. The peroxiredoxin repair proteins.
Jönsson TJ; Lowther WT
Subcell Biochem; 2007; 44():115-41. PubMed ID: 18084892
[TBL] [Abstract][Full Text] [Related]
2. Reduction of cysteine sulfinic acid in eukaryotic, typical 2-Cys peroxiredoxins by sulfiredoxin.
Lowther WT; Haynes AC
Antioxid Redox Signal; 2011 Jul; 15(1):99-109. PubMed ID: 20712415
[TBL] [Abstract][Full Text] [Related]
3. Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate.
Jönsson TJ; Murray MS; Johnson LC; Lowther WT
J Biol Chem; 2008 Aug; 283(35):23846-51. PubMed ID: 18579529
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine.
Chang TS; Jeong W; Woo HA; Lee SM; Park S; Rhee SG
J Biol Chem; 2004 Dec; 279(49):50994-1001. PubMed ID: 15448164
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the formation of a covalent thiosulfinate intermediate with peroxiredoxin in the catalytic mechanism of sulfiredoxin.
Roussel X; Béchade G; Kriznik A; Van Dorsselaer A; Sanglier-Cianferani S; Branlant G; Rahuel-Clermont S
J Biol Chem; 2008 Aug; 283(33):22371-82. PubMed ID: 18552404
[TBL] [Abstract][Full Text] [Related]
6. The rate-limiting step of sulfiredoxin is associated with the transfer of the γ-phosphate of ATP to the sulfinic acid of overoxidized typical 2-Cys peroxiredoxins.
Roussel X; Boukhenouna S; Rahuel-Clermont S; Branlant G
FEBS Lett; 2011 Feb; 585(3):574-8. PubMed ID: 21237158
[TBL] [Abstract][Full Text] [Related]
7. Protein engineering of the quaternary sulfiredoxin.peroxiredoxin enzyme.substrate complex reveals the molecular basis for cysteine sulfinic acid phosphorylation.
Jönsson TJ; Johnson LC; Lowther WT
J Biol Chem; 2009 Nov; 284(48):33305-10. PubMed ID: 19812042
[TBL] [Abstract][Full Text] [Related]
8. Differential oxidation processes of peroxiredoxin 2 dependent on the reaction with several peroxides in human red blood cells.
Ishida YI; Ichinowatari Y; Nishimoto S; Koike S; Ishii K; Ogasawara Y
Biochem Biophys Res Commun; 2019 Oct; 518(4):685-690. PubMed ID: 31472963
[TBL] [Abstract][Full Text] [Related]
9. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins.
Woo HA; Jeong W; Chang TS; Park KJ; Park SJ; Yang JS; Rhee SG
J Biol Chem; 2005 Feb; 280(5):3125-8. PubMed ID: 15590625
[TBL] [Abstract][Full Text] [Related]
10. Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin.
Jönsson TJ; Tsang AW; Lowther WT; Furdui CM
J Biol Chem; 2008 Aug; 283(34):22890-4. PubMed ID: 18593714
[TBL] [Abstract][Full Text] [Related]
11. Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.
Noh YH; Baek JY; Jeong W; Rhee SG; Chang TS
J Biol Chem; 2009 Mar; 284(13):8470-7. PubMed ID: 19176523
[TBL] [Abstract][Full Text] [Related]
12. Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.
Rhee SG; Jeong W; Chang TS; Woo HA
Kidney Int Suppl; 2007 Aug; (106):S3-8. PubMed ID: 17653208
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis and modeling of the peroxiredoxin (Prx) complex with the NMR structure of ATP-bound human sulfiredoxin implicate aspartate 187 of Prx I as the catalytic residue in ATP hydrolysis.
Lee DY; Park SJ; Jeong W; Sung HJ; Oho T; Wu X; Rhee SG; Gruschus JM
Biochemistry; 2006 Dec; 45(51):15301-9. PubMed ID: 17176052
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of peroxiredoxins and their role in the decomposition of peroxynitrite.
Trujillo M; Ferrer-Sueta G; Thomson L; Flohé L; Radi R
Subcell Biochem; 2007; 44():83-113. PubMed ID: 18084891
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 1 and its role in cell signaling.
Neumann CA; Cao J; Manevich Y
Cell Cycle; 2009 Dec; 8(24):4072-8. PubMed ID: 19923889
[TBL] [Abstract][Full Text] [Related]
16. Hyperoxidation of Peroxiredoxins: Gain or Loss of Function?
Veal EA; Underwood ZE; Tomalin LE; Morgan BA; Pillay CS
Antioxid Redox Signal; 2018 Mar; 28(7):574-590. PubMed ID: 28762774
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of the reduction of cysteine sulfinic acid of peroxiredoxin to cysteine by mammalian sulfiredoxin.
Jeong W; Park SJ; Chang TS; Lee DY; Rhee SG
J Biol Chem; 2006 May; 281(20):14400-7. PubMed ID: 16565085
[TBL] [Abstract][Full Text] [Related]
18. Deglutathionylation of 2-Cys peroxiredoxin is specifically catalyzed by sulfiredoxin.
Park JW; Mieyal JJ; Rhee SG; Chock PB
J Biol Chem; 2009 Aug; 284(35):23364-74. PubMed ID: 19561357
[TBL] [Abstract][Full Text] [Related]
19. Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol-induced oxidative injury in mouse liver.
Bae SH; Sung SH; Cho EJ; Lee SK; Lee HE; Woo HA; Yu DY; Kil IS; Rhee SG
Hepatology; 2011 Mar; 53(3):945-53. PubMed ID: 21319188
[TBL] [Abstract][Full Text] [Related]
20. Oxidation of 2-Cys-peroxiredoxins by arachidonic acid peroxide metabolites of lipoxygenases and cyclooxygenase-2.
Cordray P; Doyle K; Edes K; Moos PJ; Fitzpatrick FA
J Biol Chem; 2007 Nov; 282(45):32623-9. PubMed ID: 17855346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
